Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hanger Orthopedic Group, Inc.
Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008
November 16th, 2008
Hanger Orthopedic Group, Inc. (NYSE:HGR) announces net sales of $178.7 million for the quarter ended September 30, 2008, an increase of $16.4 million, or 10.1%, from $162.3 million in the prior year's comparable quarter. Net income for the quarter was $7.3 million, an increase of $1.9 million, or 35.7%, compared to the same quarter last year. Diluted earnings per share for the third quarter 2008 were $0.23 per share, or 27.8%, from $0.18 per share in the third quarter of last year. The $16.4 million sales increase for the quarter was primarily the result of a $10.5 million, or 7.3%, increase in same-center sales in our patient care business, a $2.9 million, or 15.9%,...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-16)
|
